Moderna (MRNA) Net Equity Issued and Repurchased (2018 - 2020)
Moderna (MRNA) posted quarterly Net Equity Issued and Repurchased of $1.3 billion for Q2 2020, up 136.91% on a QoQ basis from $550.0 million in Q1 2020.
Moderna (MRNA) Net Equity Issued and Repurchased (2018 - 2020) Analysis & Trends
Moderna has reported Net Equity Issued and Repurchased for 2 years, with the latest figure at $1.3 billion in Q2 2020.
- Net Equity Issued and Repurchased for Q2 2020 came in at $1.3 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $1.3 billion (up 136.91% YoY), and the FY2020 annual result was $1.9 billion, changed N/A from the prior year.
- Net Equity Issued and Repurchased grew to $1.3 billion in Q2 2020, from $550.0 million in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $1.3 billion in Q2 2020 and troughed at $111.6 million in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 141.90 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 1.30 Bn |
| Jun 30, 2020 | 1.30 Bn |
| Mar 31, 2020 | 550.00 Mn |
| Mar 31, 2020 | 550.00 Mn |
| Jun 30, 2018 | 111.58 Mn |
| Jun 30, 2018 | 111.58 Mn |
| Mar 31, 2018 | 549.53 Mn |
| Mar 31, 2018 | 549.53 Mn |